The AI-native platform's new patent-pending Modeler Agent enables enterprises to build and evolve complex planning models at record speed.
NervGen Pharma Corp. (“NervGen” or the “Company”) (TSXV: NGEN) (NASDAQ: NGEN), a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results